Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults

ClinicalTrials.gov ID: NCT02100631

Public ClinicalTrials.gov record NCT02100631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 O1 Serotype Inaba Strain CVD 103-HgR

Study identification

NCT ID
NCT02100631
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bavarian Nordic
Industry
Enrollment
398 participants

Conditions and interventions

Conditions

Interventions

  • PXVX0200 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
46 Years to 64 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2014
Primary completion
Jan 31, 2015
Completion
May 31, 2015
Last update posted
Jun 27, 2023

2014 – 2015

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
Coastal Clinical Research Mobile Alabama 36608
Avail Clinical DeLand Florida 32720
Miami Research Associates Miami Florida 33143
Palm Beach Research Center Palm Beach Florida 33409
Emory University Atlanta Georgia 30322
Johnson County Clin-Trials Lenexa Kansas 66219
Heartland Research Wichita Kansas 67207
Central Kentucky Research Lexington Kentucky 40509
University of Kentucky Lexington Kentucky 40536
Boston University Boston Massachusetts 02218
Center for Pharmaceutical Research Kansas City Missouri 64114
St. Louis University St Louis Missouri 63104
Coastal Carolina Research Mt. Pleasant South Carolina 29464
Research Across America Dallas Texas 75234
Jean Brown Research Salt Lake City Utah 84124
University of Vermont Burlington Vermont 05405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02100631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2023 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02100631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →